Vaccine used for preventing and treating influenza, avian influenza and upper respiratory infection
What is Al technical title?
Al technical title is built by PatSnap Al team. It summarizes the technical point description of the patent document.
A technology for upper respiratory tract and bird flu, applied in the field of medicine, can solve the problems of easy to disperse, improper use, easy to infect bird flu virus, etc.
Pending Publication Date: 2016-05-04
程龙
View PDF4 Cites 5 Cited by
Summary
Abstract
Description
Claims
Application Information
AI Technical Summary
This helps you quickly interpret patents by identifying the three key elements:
Problems solved by technology
Method used
Benefits of technology
Problems solved by technology
[0005] Existing avian influenza vaccines are mostly made of weakly toxic avian influenza viruses. The existing avian influenza vaccines have defects such
Method used
the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more
Image
Smart Image Click on the blue labels to locate them in the text.
Viewing Examples
Smart Image
Click on the blue label to locate the original text in one second.
Reading with bidirectional positioning of images and text.
Smart Image
Examples
Experimental program
Comparison scheme
Effect test
Embodiment 1
[0029] Embodiment 1 A kind of vaccine for preventing and treating influenza, bird flu, upper respiratory tract infection
[0030] The vaccine comprises marine algal glycoprotein;
[0031] The marine algae glycoprotein includes 1% sugar and 99% protein by weight content.
[0032] The molecular weight is 0.2kDa;
[0033] The marine algae are: cyanobacteria;
[0034] The sugar is a polysaccharide;
[0035] The polysaccharides include: glucose, galactose, mannose, rhamnose;
[0036] The protein includes: serine, threonine, hydroxylysine, aspartic acid;
Embodiment 2
[0037] Embodiment 2 A kind of vaccine for preventing and treating influenza, bird flu, upper respiratory tract infection
[0038] The vaccine comprises marine algal glycoprotein;
[0039] Said marine algae glycoprotein, by weight content, comprises sugar 5%, protein 82%,
[0040] The molecular weight is 3kDa;
[0041] The marine algae are: cyanobacteria;
[0042] The sugar is a polysaccharide;
[0043] The polysaccharides include: glucose, galactose, mannose, rhamnose;
[0044] The protein includes: serine, threonine, hydroxylysine, aspartic acid;
Embodiment 3
[0045] Embodiment 3 A kind of vaccine for preventing and treating influenza, bird flu, upper respiratory tract infection
[0046] The vaccine comprises marine algal glycoprotein;
[0047] Said marine algal glycoprotein, by weight content, comprises sugar 17%, protein 75%,
[0048] The molecular weight is 32kDa;
[0049] The marine algae is: green algae;
[0050] The sugar is a polysaccharide;
[0051] The polysaccharides include: glucose, galactose, mannose, rhamnose;
[0052] The protein includes: serine, threonine, hydroxylysine, aspartic acid;
the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to view more
PUM
Property
Measurement
Unit
Molecular weight
aaaaa
aaaaa
Molecular weight
aaaaa
aaaaa
Molecular weight
aaaaa
aaaaa
Login to view more
Abstract
The invention provides a vaccine used for preventing and treating influenza, avian influenza and upper respiratory infection. The vaccine is glycoprotein or a mixture of polysaccharide and protein or polypeptide or protein. After the vaccine prepared by the invention is used for immunizing SPF chickens, AIV-H5 (Avian Influenza Virus-H5) avian influenza virus antibodies are generated; after the SPF chickens are immunized, AIV-H5 avian influenza viruses can be effectively resisted and the protection rate reaches 80 percent to 93.3 percent; after the SPF chickens are immunized, NDV chicken Newcastle disease antibodies; after the SPF chickens are immunized, NDV chicken Newcastle disease viruses can be effectively resisted and the protection rate reaches 76.7 percent to 96.7 percent. The vaccine provided by the invention has functions of preventing and treating respiratory system diseases, and broad-spectrum anti-virus, anti-inflammatory, anticoagulation, bacteria resisting, antipyretic and immunity adjusting functions. The vaccine provided by the invention is safe and efficient, has no side effect, and has an obvious curative effect on preventing and treating the avian influenza; avian influenza-H5 antibody detection is negative, so that the vaccine can be used for killing the avian influenza-H5 viruses.
Description
technical field [0001] The invention relates to a vaccine for preventing and treating influenza, bird flu and upper respiratory tract infection, belonging to the technical field of medicine. Background technique [0002] Avian influenza (Avian influenza, AI) is the abbreviation of avian influenza, the acute respiratory infectious disease that is caused by a variety of poultry infection caused by avian influenza virus (Avian influenza virus, AIV), can also infect human beings, has been recognized by the International Veterinary Bureau (OIE) and my country The "Livestock and Poultry Epidemic Prevention Regulations" listed it as a Class A severe infectious disease. [0003] Influenza viruses belong to the Orthomyxoviridae family Influenzavirus genus, which contain enveloped, polymorphic negative-strand RNA viruses. Influenza viruses can be divided into three types: A (A), B (B) and C (C) according to the differences in the internal nucleoprotein (NP) and matrix protein (MP) ant...
Claims
the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to view more
Application Information
Patent Timeline
Application Date:The date an application was filed.
Publication Date:The date a patent or application was officially published.
First Publication Date:The earliest publication date of a patent with the same application number.
Issue Date:Publication date of the patent grant document.
PCT Entry Date:The Entry date of PCT National Phase.
Estimated Expiry Date:The statutory expiry date of a patent right according to the Patent Law, and it is the longest term of protection that the patent right can achieve without the termination of the patent right due to other reasons(Term extension factor has been taken into account ).
Invalid Date:Actual expiry date is based on effective date or publication date of legal transaction data of invalid patent.
Login to view more